Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | PPID | Q08752 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | TOP2A | P11388 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL133175 | 0.98 | POLB (0.59) | POLBPPIDGAAELANEALDH1A1 | |
| Alcohol SCHEMBL28628021 | 0.96 | POLB (0.57) | POLBPPIDGAAELANEALDH1A1 | |
| Acetic Acid SCHEMBL28661029 | 0.96 | POLB (0.57) | POLBPPIDGAAELANEALDH1A1 | |
| SCHEMBL11732203 | 0.95 | POLB (0.56) | POLBPPIDGAAELANEALDH1A1 | |
| Sulfuric Acid SCHEMBL28065986 | 0.93 | POLB (0.55) | POLBPPIDGAAELANEALDH1A1 | |
| Urethane SCHEMBL6105791 | 0.92 | POLB (0.54) | POLBPPIDGAAELANEALDH1A1 | |
| Urethane SCHEMBL7266227 | 0.92 | POLB (0.54) | POLBPPIDGAAELANEALDH1A1 | |
| Nitric Acid SCHEMBL27965379 | 0.91 | POLB (0.52) | POLBPPIDGAAELANEALDH1A1 | |
| SCHEMBL28250670 | 0.90 | POLB (0.58) | POLBPPIDGAAELANEALDH1A1 | |
| SCHEMBL11355645 | 0.87 | POLB (0.55) | POLBPPIDGAAELANEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118151490-B | Photosensitive resin composition, photosensitive dry film and application thereof | 湖南初源新材料股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118390075-A | Synthesis method of glycine ester compound | 中国计量大学 | 2024-07-26 | — | — | CN | claimed |
| CN-118290421-A | Chiral probe compound based on flavin skeleton and preparation and application thereof | 西北师范大学 | 2024-07-05 | — | — | CN | claimed |
| CN-118151490-A | Photosensitive resin composition, photosensitive dry film and application thereof | 湖南初源新材料股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117720446-A | Green methionine synthesis method | 新疆兴发化工有限公司 | 2024-03-19 | — | — | CN | claimed |
| US-20240027442-A1 | TEST REAGENT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE NEGATIVES | DENKA COMPANY LIMITED (JP) | 2024-01-25 | — | — | US | claimed |
| US-20240011978-A1 | TEST KIT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE POSITIVES | DENKA COMPANY LIMITED (JP) | 2024-01-11 | — | — | US | claimed |
| CN-116396352-A | Method for catalyzing selective alkylation of tryptophan-containing polypeptide by visible light | 上海大学 | 2023-07-07 | — | — | CN | claimed |
| EP-4206181-A1 | TEST REAGENT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE NEGATIVES | Denka Company Limited (JP) | 2023-07-05 | — | — | EP | claimed |
| EP-4206672-A1 | TEST KIT HAVING SPECIFICITY IMPROVED BY INHIBITING FALSE POSITIVES | Denka Company Limited (JP) | 2023-07-05 | — | — | EP | claimed |
| US-6824786-B2 | TOPICAL APPLYING COSMETIC | YU RUEY J (US) | 2004-11-30 | — | — | US | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| EP-1455734-A1 | COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES | Yu, Ruey J., Dr. (US) | 2004-09-15 | — | — | EP | claimed |
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | YU RUEY J (US) | 2003-06-12 | — | — | US | claimed |
| WO-2003045338-A1 | COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES | YU RUEY J (US) | 2003-06-05 | — | — | WO | claimed |
| EP-0703216-B1 | Amidinophenol derivatives as protease inhibitors | ONO PHARMACEUTICAL CO (JP) | 1999-04-07 | — | — | EP | claimed |
| CN-1187188-A | Small molecule inhibitors of rotamase enzyme activity | GUILFORD PHARM INC (US) | 1998-07-08 | — | — | CN | claimed |
| EP-0588655-B1 | Amidinophenol derivatives | ONO PHARMACEUTICAL CO (JP) | 1996-12-04 | — | — | EP | claimed |
| US-4337352-A | SALT FORMATION WITH OPTICALLY ACTIVE AMINE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | GRHPR, ARL1, SUCLG1 | POLB 2304/4885PPID 1809/4885GAA 1037/4885 |
| US-20240027442-A1 | TEST REAGENT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE NEGATIVES | SHBG, CD14, SARS1 | POLB 2656/4885PPID 3738/4885GAA 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.